Imexpharm Corp Free Cash Flow Generation Index

Latest as of June 2026: 0.70x

Imexpharm Corp free cash flow generation index. Imexpharm Corp (IMP) has a Free Cash Flow Generation Index of 0.70x as of June 2026. Free cash flow of ₫38.85 Billion represents 1% of operating cash flow (₫55.75 Billion).

FCF Generation Index

0.70x
Free Cash Flow / Operating CF

Free Cash Flow

₫38.85 Billion
VND

Operating Cash Flow

₫55.75 Billion
VND

Capital Expenditures

₫16.90 Billion
VND

Free Cash Flow Generation Index of Imexpharm Corp (2019–2025)

Free cash flow generation index of Imexpharm Corp from 2019 to 2025. Historical FCF Generation Index trend for Imexpharm Corp across 6 annual periods. See IMP FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Imexpharm Corp Free Cash Flow Generation Index by Year (2019–2025)

Imexpharm Corp free cash flow generation index by year from 2019 to 2025. Year-by-year Free Cash Flow Generation Index for Imexpharm Corp. For the full cash flow conversion analysis, see Imexpharm Corp operating cash flow efficiency.

Year FCG Index Free Cash Flow (VND) Operating CF Capital Expenditures YoY Change
2025 0.50x ₫27.29 Billion ₫54.17 Billion ₫26.88 Billion ▼ -8.8%
2024 0.55x ₫119.50 Billion ₫216.27 Billion ₫96.77 Billion ▼ -25.1%
2022 0.74x ₫279.25 Billion ₫378.60 Billion ₫99.35 Billion ▼ -4.8%
2021 0.77x ₫182.02 Billion ₫234.88 Billion ₫52.86 Billion ▲ +442.9%
2020 -0.23x ₫-16.53 Billion ₫73.15 Billion ₫89.68 Billion ▲ +76.7%
2019 -0.97x ₫-64.53 Billion ₫66.59 Billion ₫131.12 Billion —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).